Melatonin: Antioxidant and modulatory properties in age‐related changes during Trypanosoma cruzi infection
The purpose of this study was to investigate the effects of melatonin on selected biomarkers of innate and humoral immune response as well as the antioxidant/oxidant status (superoxide dismutase—SOD and reduced glutathione levels (GSH) to understand whether age‐related changes would influence the de...
Saved in:
Published in | Journal of pineal research Vol. 63; no. 1 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
01.08.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The purpose of this study was to investigate the effects of melatonin on selected biomarkers of innate and humoral immune response as well as the antioxidant/oxidant status (superoxide dismutase—SOD and reduced glutathione levels (GSH) to understand whether age‐related changes would influence the development of acute Trypanosoma cruzi (T. cruzi) infection. Young‐ (5 weeks) and middle‐aged (18 months) Wistar rats were orally treated with melatonin (gavage) (05 mg/kg/day), 9 days after infection. A significant increase in both SOD activity and GSH levels was found in plasma from all middle‐aged melatonin‐treated animals. Melatonin triggered enhanced expression of major histocompatibility class II (MHC‐II) antigens on antigen‐presenting cell (APC) and peritoneal macrophages in all treated animals. High levels of CD4+CD28‐negative T cells (*P<.05) were detected in middle‐aged control animals. Melatonin induced a significant reduction (***P<.001) in CD28‐negative in CD4+ and CD8+ T cells in middle‐aged control animals. Contrarily, the same group displayed upregulated CD4+CD28+T and CD8+CD28+T cells. Melatonin also triggered an upregulation of CD80 and CD86 expression in all young‐treated groups. Significant percentages of B and spleen dendritic cells in middle‐aged infected and treated animals were observed. Our data reveal new features of melatonin action in inhibiting membrane lipid peroxidation, through the reduction in 8‐isoprostane, upregulating the antioxidant defenses and triggering an effective balance in the antioxidant/oxidant status during acute infection. The ability of melatonin to counteract the immune alterations induced by aging added further support to its use as a potential therapeutic target not only for T. cruzi infection but also for other immunocompromised states. |
---|---|
AbstractList | The purpose of this study was to investigate the effects of melatonin on selected biomarkers of innate and humoral immune response as well as the antioxidant/oxidant status (superoxide dismutase-SOD and reduced glutathione levels (GSH) to understand whether age-related changes would influence the development of acute Trypanosoma cruzi (T. cruzi) infection. Young- (5 weeks) and middle-aged (18 months) Wistar rats were orally treated with melatonin (gavage) (05 mg/kg/day), 9 days after infection. A significant increase in both SOD activity and GSH levels was found in plasma from all middle-aged melatonin-treated animals. Melatonin triggered enhanced expression of major histocompatibility class II (MHC-II) antigens on antigen-presenting cell (APC) and peritoneal macrophages in all treated animals. High levels of CD4
CD28-negative T cells (*P<.05) were detected in middle-aged control animals. Melatonin induced a significant reduction (***P<.001) in CD28-negative in CD4
and CD8
T cells in middle-aged control animals. Contrarily, the same group displayed upregulated CD4
CD28
T and CD8
CD28
T cells. Melatonin also triggered an upregulation of CD80 and CD86 expression in all young-treated groups. Significant percentages of B and spleen dendritic cells in middle-aged infected and treated animals were observed. Our data reveal new features of melatonin action in inhibiting membrane lipid peroxidation, through the reduction in 8-isoprostane, upregulating the antioxidant defenses and triggering an effective balance in the antioxidant/oxidant status during acute infection. The ability of melatonin to counteract the immune alterations induced by aging added further support to its use as a potential therapeutic target not only for T. cruzi infection but also for other immunocompromised states. The purpose of this study was to investigate the effects of melatonin on selected biomarkers of innate and humoral immune response as well as the antioxidant/oxidant status (superoxide dismutase—SOD and reduced glutathione levels (GSH) to understand whether age‐related changes would influence the development of acute Trypanosoma cruzi (T. cruzi) infection. Young‐ (5 weeks) and middle‐aged (18 months) Wistar rats were orally treated with melatonin (gavage) (05 mg/kg/day), 9 days after infection. A significant increase in both SOD activity and GSH levels was found in plasma from all middle‐aged melatonin‐treated animals. Melatonin triggered enhanced expression of major histocompatibility class II (MHC‐II) antigens on antigen‐presenting cell (APC) and peritoneal macrophages in all treated animals. High levels of CD4+CD28‐negative T cells (*P<.05) were detected in middle‐aged control animals. Melatonin induced a significant reduction (***P<.001) in CD28‐negative in CD4+ and CD8+ T cells in middle‐aged control animals. Contrarily, the same group displayed upregulated CD4+CD28+T and CD8+CD28+T cells. Melatonin also triggered an upregulation of CD80 and CD86 expression in all young‐treated groups. Significant percentages of B and spleen dendritic cells in middle‐aged infected and treated animals were observed. Our data reveal new features of melatonin action in inhibiting membrane lipid peroxidation, through the reduction in 8‐isoprostane, upregulating the antioxidant defenses and triggering an effective balance in the antioxidant/oxidant status during acute infection. The ability of melatonin to counteract the immune alterations induced by aging added further support to its use as a potential therapeutic target not only for T. cruzi infection but also for other immunocompromised states. The purpose of this study was to investigate the effects of melatonin on selected biomarkers of innate and humoral immune response as well as the antioxidant/oxidant status (superoxide dismutase-SOD and reduced glutathione levels (GSH) to understand whether age-related changes would influence the development of acute Trypanosoma cruzi (T. cruzi) infection. Young- (5 weeks) and middle-aged (18 months) Wistar rats were orally treated with melatonin (gavage) (05 mg/kg/day), 9 days after infection. A significant increase in both SOD activity and GSH levels was found in plasma from all middle-aged melatonin-treated animals. Melatonin triggered enhanced expression of major histocompatibility class II (MHC-II) antigens on antigen-presenting cell (APC) and peritoneal macrophages in all treated animals. High levels of CD4+ CD28-negative T cells (*P<.05) were detected in middle-aged control animals. Melatonin induced a significant reduction (***P<.001) in CD28-negative in CD4+ and CD8+ T cells in middle-aged control animals. Contrarily, the same group displayed upregulated CD4+ CD28+ T and CD8+ CD28+ T cells. Melatonin also triggered an upregulation of CD80 and CD86 expression in all young-treated groups. Significant percentages of B and spleen dendritic cells in middle-aged infected and treated animals were observed. Our data reveal new features of melatonin action in inhibiting membrane lipid peroxidation, through the reduction in 8-isoprostane, upregulating the antioxidant defenses and triggering an effective balance in the antioxidant/oxidant status during acute infection. The ability of melatonin to counteract the immune alterations induced by aging added further support to its use as a potential therapeutic target not only for T. cruzi infection but also for other immunocompromised states. The purpose of this study was to investigate the effects of melatonin on selected biomarkers of innate and humoral immune response as well as the antioxidant/oxidant status (superoxide dismutase— SOD and reduced glutathione levels ( GSH ) to understand whether age‐related changes would influence the development of acute Trypanosoma cruzi (T. cruzi) infection. Young‐ (5 weeks) and middle‐aged (18 months) Wistar rats were orally treated with melatonin (gavage) (05 mg/kg/day), 9 days after infection. A significant increase in both SOD activity and GSH levels was found in plasma from all middle‐aged melatonin‐treated animals. Melatonin triggered enhanced expression of major histocompatibility class II ( MHC ‐ II ) antigens on antigen‐presenting cell ( APC ) and peritoneal macrophages in all treated animals. High levels of CD 4 + CD 28‐negative T cells (* P <.05) were detected in middle‐aged control animals. Melatonin induced a significant reduction (*** P <.001) in CD 28 ‐ negative in CD 4 + and CD 8 + T cells in middle‐aged control animals. Contrarily, the same group displayed upregulated CD 4 + CD 28 + T and CD 8 + CD 28 + T cells. Melatonin also triggered an upregulation of CD 80 and CD 86 expression in all young‐treated groups. Significant percentages of B and spleen dendritic cells in middle‐aged infected and treated animals were observed. Our data reveal new features of melatonin action in inhibiting membrane lipid peroxidation, through the reduction in 8‐isoprostane, upregulating the antioxidant defenses and triggering an effective balance in the antioxidant/oxidant status during acute infection. The ability of melatonin to counteract the immune alterations induced by aging added further support to its use as a potential therapeutic target not only for T. cruzi infection but also for other immunocompromised states. |
Author | Santello, Fabricia H. Mazotti, Tamires T. Tazinafo, Lucas F. Vale, Gabriel T. Prado, José C. Toldo, Míriam Paula A. Brazão, Vânia Tirapelli, Carlos R. Colato, Rafaela P. |
Author_xml | – sequence: 1 givenname: Vânia orcidid: 0000-0003-0149-4957 surname: Brazão fullname: Brazão, Vânia email: vaniabrazao@gmail.com organization: University of São Paulo – sequence: 2 givenname: Fabricia H. surname: Santello fullname: Santello, Fabricia H. organization: University of São Paulo – sequence: 3 givenname: Rafaela P. surname: Colato fullname: Colato, Rafaela P. organization: University of São Paulo – sequence: 4 givenname: Tamires T. surname: Mazotti fullname: Mazotti, Tamires T. organization: University of São Paulo – sequence: 5 givenname: Lucas F. surname: Tazinafo fullname: Tazinafo, Lucas F. organization: University of São Paulo – sequence: 6 givenname: Míriam Paula A. surname: Toldo fullname: Toldo, Míriam Paula A. organization: University of São Paulo – sequence: 7 givenname: Gabriel T. surname: Vale fullname: Vale, Gabriel T. organization: USP – sequence: 8 givenname: Carlos R. surname: Tirapelli fullname: Tirapelli, Carlos R. organization: USP – sequence: 9 givenname: José C. surname: Prado fullname: Prado, José C. organization: University of São Paulo |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28370218$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kM1O3DAURq0KVAbaBS-AvIRF4NrJ-Kc7hGgZNKhdUKm7yLGdwSixg52IDiseoc_Ik9TTge64m7u45zu6-vbRjg_eInRI4JTkObsf3CmhFcgPaEYYQAFc_tpBM-AVLUqQYg_tp3QPAEII9hHtUVFyoETMUHdjOzUG7_wXfO5HF347o_yIlTe4D2baHOMaDzEMNo7OJuw8Viv78vwnbpLWYH2n_CofzBSdX-HbuB6UDyn0Cus4PbmcaK3Oav8J7baqS_bz6z5AP79e3l5cFcvv3xYX58tCl3QuCzo3smp4qdqK8VbyRutSa0rKBlot2ZwyJjUHIoy2jQZQjDKpOCfUtC0FUh6g4603v_0w2TTWvUvadp3yNkypJkJUhFVVKTN6skV1DClF29ZDdL2K65pAvSm3zuXW_8rN7NGrdmp6a_6Tb21m4GwLPLrOrt831dc_FlvlX7yViEI |
CitedBy_id | crossref_primary_10_1038_s41598_020_67103_5 crossref_primary_10_3390_antiox10040577 crossref_primary_10_1080_09291016_2018_1424769 crossref_primary_10_2174_0929867325666180410094149 crossref_primary_10_1111_jpi_12710 crossref_primary_10_1139_cjpp_2020_0473 crossref_primary_10_1111_jpi_12899 crossref_primary_10_3390_ijms20163921 crossref_primary_10_1186_s12935_019_0778_1 crossref_primary_10_1111_jpi_12455 crossref_primary_10_1111_jpi_12510 crossref_primary_10_1016_j_biochi_2023_07_021 crossref_primary_10_3390_molecules23020509 crossref_primary_10_1016_j_lfs_2019_117191 crossref_primary_10_1097_FJC_0000000000000678 crossref_primary_10_3390_molecules23020301 crossref_primary_10_4155_fmc_2023_0177 crossref_primary_10_1002_jcp_28273 crossref_primary_10_1007_s11064_019_02791_8 crossref_primary_10_1155_2023_7873399 crossref_primary_10_1016_j_exger_2020_110922 crossref_primary_10_1016_j_plaphy_2019_07_012 crossref_primary_10_1111_jpn_13675 crossref_primary_10_1007_s12035_024_03915_0 crossref_primary_10_1007_s11427_021_2032_9 crossref_primary_10_1111_jpi_12547 crossref_primary_10_1016_j_cyto_2018_08_004 crossref_primary_10_1007_s00018_017_2618_6 crossref_primary_10_1007_s12035_020_02212_w crossref_primary_10_1007_s10735_018_09809_5 crossref_primary_10_1016_j_exger_2022_111895 crossref_primary_10_1111_brv_12898 crossref_primary_10_3390_antiox10071022 |
Cites_doi | 10.1152/physiol.00011.2014 10.1016/j.immuni.2006.05.003 10.1007/s40279-015-0348-1 10.1111/j.1600-079X.2009.00708.x 10.1111/jpi.12090 10.1016/j.coi.2004.01.009 10.33549/physiolres.932890 10.1111/jpi.12010 10.1253/circj.CJ-09-0491 10.1126/science.286.5438.304 10.1385/ENDO:27:2:201 10.1111/jpi.12360 10.1016/j.biocel.2006.07.001 10.1016/j.gheart.2015.06.001 10.1016/j.freeradbiomed.2004.09.017 10.1111/j.1600-079X.2007.00427.x 10.1111/j.1600-079X.2010.00810.x 10.1081/IMM-100103687 10.1038/sj.bjp.0702826 10.1086/529197 10.1111/j.1600-079X.1991.tb00827.x 10.1016/j.actatropica.2009.10.023 10.1007/978-1-61779-170-3_13 10.1172/JCI11696 10.4049/jimmunol.161.10.5193 10.2174/1874196701003010039 10.1016/j.vph.2015.06.015 10.1161/JAHA.113.000539 10.1016/j.exger.2007.06.008 10.1016/0192-0561(93)90060-C 10.4049/jimmunol.168.11.5893 10.1128/IAI.00497-12 10.1385/ENDO:27:2:119 10.2741/Pawelec 10.1007/s10875-010-9449-7 10.1155/2009/190354 10.1186/1742-4933-2-17 10.1080/00034983.1969.11686622 10.1111/j.1742-7843.2010.00546.x 10.1016/j.coi.2007.04.001 10.1016/j.coi.2009.05.023 10.7555/JBR.30.2016K0010 10.1111/jpi.12189 10.1111/jpi.12280 10.1159/000109532 10.1111/j.1600-079X.2006.00394.x 10.1111/jpi.12267 10.1016/j.freeradbiomed.2004.09.011 10.3390/ijms14048638 10.1007/s00262-012-1293-6 10.1111/j.1600-079X.2004.00196.x 10.1007/s12640-012-9337-4 10.1016/j.neurobiolaging.2006.06.008 10.1128/IAI.71.6.3131-3137.2003 10.1126/sageke.2002.50.re5 10.1111/jpi.12207 10.1155/2013/267078 10.1152/physiol.00040.2007 10.1371/journal.pntd.0002364 10.1155/2014/562860 |
ContentType | Journal Article |
Copyright | 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. |
Copyright_xml | – notice: 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd – notice: 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1111/jpi.12409 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
EISSN | 1600-079X |
EndPage | n/a |
ExternalDocumentID | 10_1111_jpi_12409 28370218 JPI12409 |
Genre | article Journal Article |
GrantInformation_xml | – fundername: FAPESP |
GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 186 1OB 1OC 29L 31~ 33P 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAKAS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABDBF ABEML ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACMXC ACPOU ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZCM ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFZJQ AHBTC AHEFC AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BQCPF BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DC6 DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EAD EAP EBC EBD EBS EBX EJD EMB EMK EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ SV3 TEORI TUS UB1 V8K W8V W99 WBKPD WIH WIJ WIK WNSPC WOHZO WOW WQJ WRC WXI WXSBR WYISQ XG1 YFH YUY ZZTAW ~IA ~WT CGR CUY CVF ECM EIF NPM AAMNL AAYXX ACRPL ACYXJ CITATION 7X8 |
ID | FETCH-LOGICAL-c3259-25d94b73af467f97bcc3cc213b0fc9652669c7018dcebc00a6269a7712dff2013 |
IEDL.DBID | DR2 |
ISSN | 0742-3098 |
IngestDate | Wed Dec 04 01:19:31 EST 2024 Fri Dec 06 03:38:37 EST 2024 Sat Sep 28 08:47:41 EDT 2024 Sat Aug 24 01:04:32 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | melatonin immune response antioxidant protection Trypanosoma cruzi |
Language | English |
License | 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. http://onlinelibrary.wiley.com/termsAndConditions#vor |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3259-25d94b73af467f97bcc3cc213b0fc9652669c7018dcebc00a6269a7712dff2013 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-0149-4957 |
PMID | 28370218 |
PQID | 1884164439 |
PQPubID | 23479 |
PageCount | 11 |
ParticipantIDs | proquest_miscellaneous_1884164439 crossref_primary_10_1111_jpi_12409 pubmed_primary_28370218 wiley_primary_10_1111_jpi_12409_JPI12409 |
PublicationCentury | 2000 |
PublicationDate | August 2017 2017-Aug 2017-08-00 20170801 |
PublicationDateYYYYMMDD | 2017-08-01 |
PublicationDate_xml | – month: 08 year: 2017 text: August 2017 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Journal of pineal research |
PublicationTitleAlternate | J Pineal Res |
PublicationYear | 2017 |
References | 2007; 39 2012; 61 2009; 47 2011; 758 2013; 2 2010; 107 2015; 73 1991; 10 2013; 23 1999; 286 2016; 30 2014; 29 1999; 128 2013; 7 2005; 27 2001; 107 2007; 28 2002; 2002 2013; 19 2015; 45 2009; 2009 2013; 14 2013; 55 2013; 54 2006; 24 2013; 2013 2011; 71 2008; 29 2010; 115 2004; 37 2008; 23 2010; 3 2005; 38 2010; 74 2010; 30 1998; 161 1953; 20 2015; 59 2007; 19 2015; 58 1990; 32 2009; 21 2015; 10 1999; 4 2014; 2014 2003; 71 2007; 15 1993; 15 2004; 50 2004; 16 1969; 63 2015; 64 2002; 168 2011; 50 2013; 81 2008; 46 2016; 61 2008; 43 2005; 2 2007; 42 1994; 3 2001; 30 e_1_2_8_28_1 Chou JP (e_1_2_8_59_1) 2013; 19 e_1_2_8_24_1 e_1_2_8_26_1 e_1_2_8_49_1 e_1_2_8_68_1 Silva LHP (e_1_2_8_22_1) 1953; 20 e_1_2_8_3_1 e_1_2_8_5_1 e_1_2_8_9_1 e_1_2_8_20_1 e_1_2_8_43_1 e_1_2_8_66_1 e_1_2_8_45_1 e_1_2_8_64_1 Ciubotariu R (e_1_2_8_61_1) 1998; 161 e_1_2_8_62_1 e_1_2_8_41_1 e_1_2_8_60_1 e_1_2_8_17_1 Cardinali DP (e_1_2_8_19_1) 2011; 71 e_1_2_8_13_1 Wang J (e_1_2_8_33_1) 1990; 32 e_1_2_8_36_1 Doghramji K (e_1_2_8_7_1) 2007; 15 e_1_2_8_15_1 e_1_2_8_38_1 e_1_2_8_57_1 Mladenov M (e_1_2_8_32_1) 2015; 64 e_1_2_8_55_1 e_1_2_8_11_1 e_1_2_8_34_1 e_1_2_8_53_1 e_1_2_8_51_1 e_1_2_8_30_1 Reiter RJ (e_1_2_8_39_1) 2008; 29 e_1_2_8_25_1 e_1_2_8_46_1 De la Fuente M (e_1_2_8_29_1) 2004; 50 e_1_2_8_27_1 e_1_2_8_48_1 e_1_2_8_2_1 e_1_2_8_4_1 e_1_2_8_6_1 e_1_2_8_8_1 e_1_2_8_21_1 e_1_2_8_42_1 e_1_2_8_67_1 e_1_2_8_23_1 e_1_2_8_44_1 e_1_2_8_65_1 e_1_2_8_63_1 e_1_2_8_40_1 e_1_2_8_18_1 e_1_2_8_14_1 e_1_2_8_35_1 e_1_2_8_16_1 e_1_2_8_37_1 e_1_2_8_58_1 e_1_2_8_10_1 e_1_2_8_31_1 e_1_2_8_56_1 e_1_2_8_12_1 e_1_2_8_54_1 e_1_2_8_52_1 Praticò D (e_1_2_8_47_1) 2002; 2002 e_1_2_8_50_1 |
References_xml | – volume: 63 start-page: 215 year: 1969 end-page: 220 article-title: The behavior of slender and stout forms of in the blood‐stream of normal and immune mice publication-title: Ann Trop Med Parasitol – volume: 29 start-page: 325 year: 2014 end-page: 333 article-title: Melatonin: exceeding expectations publication-title: Physiology (Bethesda) – volume: 38 start-page: 145 year: 2005 end-page: 152 article-title: The human pineal gland and melatonin in aging and Alzheimer's disease publication-title: J Pineal Res – volume: 7 start-page: e2364 year: 2013 article-title: Innate immune responses and antioxidant/oxidant imbalance are major determinants of human Chagas disease publication-title: PLoS Negl Trop Dis – volume: 2002 start-page: re5 year: 2002 article-title: Lipid peroxidation and the aging process publication-title: Sci Aging Knowledge Environ – volume: 2009 start-page: 190354 year: 2009 article-title: Oxidative Stress in Chagas Disease publication-title: Interdiscip Perspect Infect Dis – volume: 29 start-page: 391 year: 2008 end-page: 398 article-title: Biogenic amines in the reduction of oxidative stress: melatonin and its metabolites publication-title: Neuro Endocrinol Lett – volume: 59 start-page: 403 year: 2015 end-page: 419 article-title: Melatonin: an ancient molecule that makes oxygen metabolically tolerable publication-title: J Pineal Res – volume: 55 start-page: 325 year: 2013 end-page: 356 article-title: Melatonin and the theories of aging: a critical appraisal of melatonin's role in antiaging mechanisms publication-title: J Pineal Res – volume: 30 start-page: 798 year: 2010 end-page: 805 article-title: Sustained CD28 expression delays multiple features of replicative senescence in human CD8 T lymphocytes publication-title: J Clin Immunol – volume: 28 start-page: 1340 year: 2007 end-page: 1360 article-title: Alzheimer's disease, oxidative stress and gammahydroxybutyrate publication-title: Neurobiol Aging – volume: 43 start-page: 61 year: 2008 end-page: 65 article-title: The immune system in extreme longevity publication-title: Exp Gerontol – volume: 20 start-page: 191 year: 1953 end-page: 201 article-title: Sobre uma cepa de altamente virulenta para o camundongo branco publication-title: Folha Clin Biol – volume: 2013 start-page: 267078 year: 2013 article-title: Immunosenescence, aging, and systemic lupus erythematous publication-title: Autoimmune Dis – volume: 19 start-page: 1680 year: 2013 end-page: 1698 article-title: T cell replicative senescence in human aging publication-title: Curr Pharm Des – volume: 128 start-page: 1241 year: 1999 end-page: 1251 article-title: Beneficial effects of Mn(III)tetrakis (4‐benzoic acid) porphyrin (MnTBAP), a superoxide dismutase mimetic, in zymosan‐induced shock publication-title: Br J Pharmacol – volume: 24 start-page: 491 year: 2006 end-page: 494 article-title: Aging and innate immunity publication-title: Immunity – volume: 32 start-page: 31 year: 1990 end-page: 41 article-title: Oxygen derived free radicals induced cellular injury in superior mesenteric artery occlusion shock: protective effect of superoxide dismutase publication-title: Circ Shock – volume: 45 start-page: 1245 year: 2015 end-page: 1261 article-title: Radical oxygen species, exercise and aging: an update publication-title: Sports Med – volume: 10 start-page: 139 year: 2015 end-page: 144 article-title: The burden of Chagas disease: estimates and challenges publication-title: Glob Heart – volume: 73 start-page: 124 year: 2015 end-page: 137 article-title: Contribution of oxidative stress and prostanoids in endothelial dysfunction induced by chronic fluoxetine treatment publication-title: Vascul Pharmacol – volume: 71 start-page: 3131 year: 2003 end-page: 3137 article-title: Critical contribution of CD28 CD80/CD86 costimulatory pathway to protection from infection publication-title: Infect Immun – volume: 2014 start-page: 562860 year: 2014 article-title: Multimarker screening of oxidative stress in aging publication-title: Oxid Med Cell Longev – volume: 115 start-page: 55 year: 2010 end-page: 68 article-title: Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches publication-title: Acta Trop – volume: 23 start-page: 267 year: 2013 end-page: 300 article-title: Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes publication-title: Neurotox Res – volume: 47 start-page: 253 year: 2009 end-page: 259 article-title: Melatonin and dehydroepiandrosterone combination: does this treatment exert a synergistic effect during experimental infection? publication-title: J Pineal Res – volume: 19 start-page: 294 year: 2007 end-page: 300 article-title: The T cell repertoire in infection and vaccination: implications for control of persistent viruses publication-title: Curr Opin Immunol – volume: 58 start-page: 210 year: 2015 end-page: 218 article-title: Immunoregulatory actions of melatonin and zinc during chronic infection publication-title: J Pineal Res – volume: 50 start-page: 64 year: 2011 end-page: 70 article-title: Melatonin triggers PKA activation in the rodent malaria parasite Plasmodium chabaudi publication-title: J Pineal Res – volume: 74 start-page: 353 year: 2010 end-page: 360 article-title: Age‐induced reduction in mitochondrial manganese superoxide dismutase activity and tolerance of macrophages against apoptosis induced by oxidized low density lipoprotein publication-title: Circ J – volume: 14 start-page: 8638 year: 2013 end-page: 8683 article-title: Melatonin: buffering the immune system publication-title: Int J Mol Sci – volume: 2 start-page: 17 year: 2005 article-title: Melatonin, immune function and aging publication-title: Immun Ageing – volume: 61 start-page: 253 year: 2016 end-page: 278 article-title: Melatonin as an antioxidant: under promises but over delivers publication-title: J Pineal Res – volume: 23 start-page: 64 year: 2008 end-page: 74 article-title: Aging of the immune system as a prognostic factor for human longevity publication-title: Physiology (Bethesda) – volume: 3 start-page: 39 year: 2010 end-page: 52 article-title: New vistas on oxidative damage and aging publication-title: Open Biol J – volume: 27 start-page: 119 year: 2005 end-page: 130 article-title: Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance publication-title: Endocrine – volume: 46 start-page: 1078 year: 2008 end-page: 1084 article-title: Biology of immune responses to vaccines in elderly persons publication-title: Clin Infect Dis – volume: 10 start-page: 117 year: 1991 end-page: 121 article-title: Melatonin‐induced enhancement of antibody‐dependent cellular cytotoxicity publication-title: J Pineal Res – volume: 39 start-page: 44 year: 2007 end-page: 84 article-title: Free radicals and antioxidants in normal physiological functions and human disease publication-title: Int J Biochem Cell Biol – volume: 54 start-page: 245 year: 2013 end-page: 257 article-title: On the free radical scavenging activities of melatonin's metabolites AFMK and AMK publication-title: J Pineal Res – volume: 15 start-page: 17 year: 2007 end-page: 23 article-title: Melatonin and its receptors: a new class of sleep‐promoting agents publication-title: J Clin Sleep Med – volume: 2 start-page: e000539 year: 2013 article-title: Pathogenesis of chagas cardiomyopathy: role of inflammation and oxidative stress publication-title: J Am Heart Assoc – volume: 4 start-page: D216 year: 1999 end-page: D269 article-title: T cells and aging (update February 1999) publication-title: Front Biosci – volume: 16 start-page: 151 year: 2004 end-page: 156 article-title: Aging, immunity and cancer publication-title: Curr Opin Immunol – volume: 168 start-page: 5893 year: 2002 end-page: 5899 article-title: Lack of antibody production following immunization in old age: association with CD8 CD28 T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines publication-title: J Immunol – volume: 71 start-page: 477 year: 2011 end-page: 483 article-title: Melatonin in Chagas’ disease. Possible therapeutic value publication-title: Medicina (B Aires) – volume: 21 start-page: 418 year: 2009 end-page: 424 article-title: Immunosenescence: what does it mean to health outcomes in older adults? publication-title: Curr Opin Immunol – volume: 61 start-page: 1327 year: 2012 end-page: 1341 article-title: The expression, function, and clinical relevance of B7 family members in cancer publication-title: Cancer Immunol Immunother – volume: 107 start-page: 485 year: 2001 end-page: 493 article-title: IFN gamma‐dependent transcription of MHC class II IA is impaired in macrophages from aged mice publication-title: J Clin Invest – volume: 758 start-page: 195 year: 2011 end-page: 204 article-title: Measurement of isoprostanes as markers of oxidative stress publication-title: Methods Mol Biol – volume: 161 start-page: 5193 year: 1998 end-page: 5202 article-title: Specific suppression of human CD4 Th cell responses to pig MHC antigens by CD8 CD28 Regulator T cells publication-title: J Immunol – volume: 58 start-page: 1 year: 2015 end-page: 11 article-title: Melatonin feedback on clock genes: a theory involving the proteasome publication-title: J Pineal Res – volume: 30 start-page: 314 year: 2016 end-page: 321 article-title: Pharmacological advantages of melatonin in immunosenescence by improving activity of T lymphocytes publication-title: J Biomed Res – volume: 50 start-page: 683 year: 2004 end-page: 690 article-title: Changes with age in peritoneal macrophage functions. Implication of leukocytes in the oxidative stress of senescence publication-title: Cell Mol Biol – volume: 59 start-page: 488 year: 2015 end-page: 496 article-title: Interleukin‐17, oxidative stress, and inflammation: role of melatonin during infection publication-title: J Pineal Res – volume: 81 start-page: 2278 year: 2013 end-page: 2287 article-title: The Absence of Myocardial Calcium‐Independent Phospholipase A2γ Results in Impaired Prostaglandin E2 Production and Decreased Survival in Mice with Acute Infection publication-title: Infect Immun – volume: 42 start-page: 359 year: 2007 end-page: 363 article-title: Melatonin treatment reduces the severity of experimental infection publication-title: J Pineal Res – volume: 27 start-page: 201 year: 2005 end-page: 212 article-title: Melatonin, aging, and age‐related diseases: perspectives for prevention, intervention, and therapy publication-title: Endocrine – volume: 3 start-page: 107 year: 1994 end-page: 117 article-title: Evidence for a direct action of melatonin on the immune system publication-title: Biol Signals – volume: 286 start-page: 304 year: 1999 end-page: 306 article-title: A nonpeptidyl mimic of superoxide dismutase with therapeutic activity in rats publication-title: Science – volume: 37 start-page: 2072 year: 2004 end-page: 2081 article-title: Oxidative modification of mitochondrial respiratory complexes in response to the stress of infection publication-title: Free Radic Biol Med – volume: 64 start-page: 891 year: 2015 end-page: 896 article-title: The relationship between antioxidant enzymes and lipid peroxidation in senescent rat erythrocytes publication-title: Physiol Res – volume: 107 start-page: 590 year: 2010 end-page: 597 article-title: Melatonin counteracts alterations in oxidative metabolism and cell viability induced by intracellular calcium overload in human leucocytes: changes with age publication-title: Basic Clin Pharmacol Toxicol – volume: 30 start-page: 17 year: 2001 end-page: 20 article-title: The effects of melatonin on humoral immune responses of young and aged rats publication-title: Immunol Invest – volume: 15 start-page: 463 year: 1993 end-page: 468 article-title: Melatonin increases antigen presentation and amplifies specific and non specific signals for t‐cell proliferation publication-title: Int J Immunopharmacol – volume: 42 start-page: 153 year: 2007 end-page: 158 article-title: Effect of melatonin on the oxidative stress in erythrocytes of healthy young and elderly subjects publication-title: J Pineal Res – volume: 38 start-page: 698 year: 2005 end-page: 710 article-title: Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? publication-title: Free Radic Biol Med – volume: 29 start-page: 391 year: 2008 ident: e_1_2_8_39_1 article-title: Biogenic amines in the reduction of oxidative stress: melatonin and its metabolites publication-title: Neuro Endocrinol Lett contributor: fullname: Reiter RJ – ident: e_1_2_8_2_1 doi: 10.1152/physiol.00011.2014 – ident: e_1_2_8_54_1 doi: 10.1016/j.immuni.2006.05.003 – ident: e_1_2_8_43_1 doi: 10.1007/s40279-015-0348-1 – ident: e_1_2_8_16_1 doi: 10.1111/j.1600-079X.2009.00708.x – ident: e_1_2_8_5_1 doi: 10.1111/jpi.12090 – ident: e_1_2_8_13_1 doi: 10.1016/j.coi.2004.01.009 – volume: 64 start-page: 891 year: 2015 ident: e_1_2_8_32_1 article-title: The relationship between antioxidant enzymes and lipid peroxidation in senescent rat erythrocytes publication-title: Physiol Res doi: 10.33549/physiolres.932890 contributor: fullname: Mladenov M – ident: e_1_2_8_4_1 doi: 10.1111/jpi.12010 – volume: 32 start-page: 31 year: 1990 ident: e_1_2_8_33_1 article-title: Oxygen derived free radicals induced cellular injury in superior mesenteric artery occlusion shock: protective effect of superoxide dismutase publication-title: Circ Shock contributor: fullname: Wang J – ident: e_1_2_8_30_1 doi: 10.1253/circj.CJ-09-0491 – ident: e_1_2_8_35_1 doi: 10.1126/science.286.5438.304 – volume: 50 start-page: 683 year: 2004 ident: e_1_2_8_29_1 article-title: Changes with age in peritoneal macrophage functions. Implication of leukocytes in the oxidative stress of senescence publication-title: Cell Mol Biol contributor: fullname: De la Fuente M – ident: e_1_2_8_10_1 doi: 10.1385/ENDO:27:2:201 – ident: e_1_2_8_37_1 doi: 10.1111/jpi.12360 – ident: e_1_2_8_42_1 doi: 10.1016/j.biocel.2006.07.001 – ident: e_1_2_8_14_1 doi: 10.1016/j.gheart.2015.06.001 – ident: e_1_2_8_25_1 doi: 10.1016/j.freeradbiomed.2004.09.017 – ident: e_1_2_8_15_1 doi: 10.1111/j.1600-079X.2007.00427.x – volume: 71 start-page: 477 year: 2011 ident: e_1_2_8_19_1 article-title: Melatonin in Chagas’ disease. Possible therapeutic value publication-title: Medicina (B Aires) contributor: fullname: Cardinali DP – ident: e_1_2_8_20_1 doi: 10.1111/j.1600-079X.2010.00810.x – ident: e_1_2_8_68_1 doi: 10.1081/IMM-100103687 – ident: e_1_2_8_34_1 doi: 10.1038/sj.bjp.0702826 – ident: e_1_2_8_51_1 doi: 10.1086/529197 – ident: e_1_2_8_66_1 doi: 10.1111/j.1600-079X.1991.tb00827.x – ident: e_1_2_8_21_1 doi: 10.1016/j.actatropica.2009.10.023 – ident: e_1_2_8_26_1 doi: 10.1007/978-1-61779-170-3_13 – ident: e_1_2_8_53_1 doi: 10.1172/JCI11696 – volume: 161 start-page: 5193 year: 1998 ident: e_1_2_8_61_1 article-title: Specific suppression of human CD4+ Th cell responses to pig MHC antigens by CD8+ CD28− Regulator T cells publication-title: J Immunol doi: 10.4049/jimmunol.161.10.5193 contributor: fullname: Ciubotariu R – ident: e_1_2_8_9_1 doi: 10.2174/1874196701003010039 – ident: e_1_2_8_24_1 doi: 10.1016/j.vph.2015.06.015 – ident: e_1_2_8_45_1 doi: 10.1161/JAHA.113.000539 – volume: 20 start-page: 191 year: 1953 ident: e_1_2_8_22_1 article-title: Sobre uma cepa de Trypanosoma cruzi altamente virulenta para o camundongo branco publication-title: Folha Clin Biol contributor: fullname: Silva LHP – ident: e_1_2_8_63_1 doi: 10.1016/j.exger.2007.06.008 – ident: e_1_2_8_55_1 doi: 10.1016/0192-0561(93)90060-C – ident: e_1_2_8_62_1 doi: 10.4049/jimmunol.168.11.5893 – ident: e_1_2_8_44_1 doi: 10.1128/IAI.00497-12 – ident: e_1_2_8_36_1 doi: 10.1385/ENDO:27:2:119 – ident: e_1_2_8_12_1 doi: 10.2741/Pawelec – ident: e_1_2_8_60_1 doi: 10.1007/s10875-010-9449-7 – ident: e_1_2_8_27_1 doi: 10.1155/2009/190354 – ident: e_1_2_8_8_1 doi: 10.1186/1742-4933-2-17 – volume: 19 start-page: 1680 year: 2013 ident: e_1_2_8_59_1 article-title: T cell replicative senescence in human aging publication-title: Curr Pharm Des contributor: fullname: Chou JP – ident: e_1_2_8_23_1 doi: 10.1080/00034983.1969.11686622 – ident: e_1_2_8_31_1 doi: 10.1111/j.1742-7843.2010.00546.x – ident: e_1_2_8_49_1 doi: 10.1016/j.coi.2007.04.001 – ident: e_1_2_8_52_1 doi: 10.1016/j.coi.2009.05.023 – ident: e_1_2_8_64_1 doi: 10.7555/JBR.30.2016K0010 – ident: e_1_2_8_6_1 doi: 10.1111/jpi.12189 – ident: e_1_2_8_18_1 doi: 10.1111/jpi.12280 – ident: e_1_2_8_67_1 doi: 10.1159/000109532 – ident: e_1_2_8_38_1 doi: 10.1111/j.1600-079X.2006.00394.x – ident: e_1_2_8_3_1 doi: 10.1111/jpi.12267 – ident: e_1_2_8_28_1 doi: 10.1016/j.freeradbiomed.2004.09.011 – ident: e_1_2_8_65_1 doi: 10.3390/ijms14048638 – ident: e_1_2_8_56_1 doi: 10.1007/s00262-012-1293-6 – ident: e_1_2_8_11_1 doi: 10.1111/j.1600-079X.2004.00196.x – ident: e_1_2_8_40_1 doi: 10.1007/s12640-012-9337-4 – ident: e_1_2_8_41_1 doi: 10.1016/j.neurobiolaging.2006.06.008 – ident: e_1_2_8_58_1 doi: 10.1128/IAI.71.6.3131-3137.2003 – volume: 2002 start-page: re5 year: 2002 ident: e_1_2_8_47_1 article-title: Lipid peroxidation and the aging process publication-title: Sci Aging Knowledge Environ doi: 10.1126/sageke.2002.50.re5 contributor: fullname: Praticò D – volume: 15 start-page: 17 year: 2007 ident: e_1_2_8_7_1 article-title: Melatonin and its receptors: a new class of sleep‐promoting agents publication-title: J Clin Sleep Med contributor: fullname: Doghramji K – ident: e_1_2_8_17_1 doi: 10.1111/jpi.12207 – ident: e_1_2_8_57_1 doi: 10.1155/2013/267078 – ident: e_1_2_8_50_1 doi: 10.1152/physiol.00040.2007 – ident: e_1_2_8_46_1 doi: 10.1371/journal.pntd.0002364 – ident: e_1_2_8_48_1 doi: 10.1155/2014/562860 |
SSID | ssj0008886 |
Score | 2.41686 |
Snippet | The purpose of this study was to investigate the effects of melatonin on selected biomarkers of innate and humoral immune response as well as the... |
SourceID | proquest crossref pubmed wiley |
SourceType | Aggregation Database Index Database Publisher |
SubjectTerms | Aging Animals antioxidant protection Antioxidants - pharmacology CD28 Antigens - metabolism Chagas Disease - immunology Chagas Disease - metabolism immune response Macrophages, Peritoneal - drug effects Male melatonin Melatonin - pharmacology Oxidative Stress - drug effects Oxidoreductases - metabolism Rats Rats, Wistar Trypanosoma cruzi |
Title | Melatonin: Antioxidant and modulatory properties in age‐related changes during Trypanosoma cruzi infection |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjpi.12409 https://www.ncbi.nlm.nih.gov/pubmed/28370218 https://search.proquest.com/docview/1884164439 |
Volume | 63 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB5CTrn0ke1jkyYopZRevNiWH1JyWvIgDaSUkkAOBaOXwbRrG3sN3T31J-Q35pdkJK-3SUuh9OaDLWyPZvTN6JtPAO98LZnggnomjSIvSnLjsThhnlAs1TRWiXFnHV5-Ss6vo4ub-GYDjoZemF4fYl1ws57h4rV1cCHbh05eFxNcnFzzXkBTS-c7-fJLOgozu6SX4Aw96nO2UhVyLJ7hycdr0R8A8zFedQvO2VP4OrxqzzP5NunmcqKWv6k4_ue3PIMnKyBKpv3MeQ4bptyG0bTEJHy2IO-Jo4a6mvsIvl9aypwt3B6SqaVH_ig0WoSIUpNZpe0JYFWzILUt7DdWoZUUJcFAdffz1vXKGE36BuOW9G2R5KpZYBiq2momiGq6ZUEGVlj5Aq7PTq-Oz73VMQ2eopg8eWGseSRTKnIMujlPpVJUqTCg0s8VT2KEAFylfsC0MlL5vsAcios0DUKd54g_6EvYLKvSvAaSMMZx9vAQ09JI-aGMNFXU7kwGmDoZNoa3g8GyulfjyNZZTF1k7h-O4WAwZYa-YjdARGmqrs0CZjdZI8RgY3jV23g9jFMBQrwzhg_OUn8fP7v4_NFd7Pz7rbuwFVo84JiDb2Bz3nRmD9HMXO67aXsP-_Dxvg |
link.rule.ids | 314,780,784,1375,27924,27925,46294,46718 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NT9tAEB0hOMClpUBLgJZtVSEujmyvP3arXqKWKNAEVVWQuFTWenctWTR25CQS4cRP4Df2l3R2HacFhIR688Fe2Z6d3Tczb94CfHRVygQX1NFxEDhBlGmHhRFzhGSxoqGMtD3rcHAe9S6Cs8vwcgU-N70wtT7EMuFmPMOu18bBTUL6Xy8f523cnUz33hq6u2cIXV9__BWPwtguqkU4fYe6nC10hSyPp3n0_m70CGLeR6x2y-m-hJ_Ny9ZMk6v2bJq25c0DHcf__ZpNeLHAoqRTT55XsKKLLdjuFBiHj-bkiFh2qE27b8OvgWHNmdztJ9IxDMnrXKFRiCgUGZXKHAJWVnMyNrn9yoi0krwguFb9vr2z7TJakbrHeELqzkgyrOa4EpWTciSIrGY3OWmIYcUOXHRPhl96zuKkBkdSjJ8cP1Q8SGMqMjRExuNUSiql79HUzSSPQkQBXMaux5TUqXRdgWEUF3Hs-SrLEILQ17BalIXeBRIxxnECcR8j00C6fhooKqkpTnoYPWnWgg-NxZJxLciRLAOZcZ7Yf9iC940tE3QXUwMRhS5nk8Rjps4aIAxrwZvayMthrBAQQp4WHFtTPT1-cvb91F7sPf_WQ1jvDQf9pH96_m0fNnwDDyyR8ABWp9VMv0VwM03f2Tn8Bx509d8 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Na9wwEB1CCqWXJm3aZpOmUUoJuXixLdmWmtPSZMlHE0JJIIeCkSUZTLK28e5CN6f-hP7G_pKO5PW2aQmE3nywhe3RjN4bzTwBfPB1xqWQ1DMJYx6Lc-PxKOaeVDzRNFKxcWcdnp3HR1fs5Dq6XoL9rhem1YdYJNysZ7h4bR281vmfTl4XfVycbPPeExaHwgrnH3z5rR2F1C5uNThDj_qCz2WFXBlP9-j9xegfhHkfsLoVZ7gCX7t3bQtNbvrTSdZXd3_JOP7nx6zC8zkSJYN26ryAJVO-hLVBiSx8NCO7xNWGuqT7Gtye2Zo5m7n9SAa2PvJbodEkRJaajCptjwCrmhmpbWa_sRKtpCgJRqqf33-4ZhmjSdthPCZtXyS5bGYYh6pxNZJENdO7gnRlYeUruBoeXn468ubnNHiKInvywkgLliVU5hh1c5FkSlGlwoBmfq5EHCEGECrxA66VyZTvSyRRQiZJEOo8RwBCX8NyWZVmHUjMucDpI0LkpUz5YcY0VdRuTQbInQzvwfvOYGndynGkCxpTF6n7hz3Y6UyZorPYHRBZmmo6TgNud1kZgrAevGltvBjGyQAh4OnBnrPUw-OnJxfH7mLj8bduw9OLg2H6-fj8dBOehRYbuCrCt7A8aaZmC5HNJHvnZvAvT870jg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Melatonin%3A+Antioxidant+and+modulatory+properties+in+age-related+changes+during+Trypanosoma+cruzi+infection&rft.jtitle=Journal+of+pineal+research&rft.au=Braz%C3%A3o%2C+V%C3%A2nia&rft.au=Santello%2C+Fabricia+H&rft.au=Colato%2C+Rafaela+P&rft.au=Mazotti%2C+Tamires+T&rft.date=2017-08-01&rft.eissn=1600-079X&rft.volume=63&rft.issue=1&rft_id=info:doi/10.1111%2Fjpi.12409&rft_id=info%3Apmid%2F28370218&rft.externalDocID=28370218 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0742-3098&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0742-3098&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0742-3098&client=summon |